Android app Apple app link

NHS to restrict new weight-loss drug Mounjaro to 220,000 patients in England initially

By The Guardian   |   1 year ago
NHS to restrict new weight-loss drug Mounjaro to 220,000 patients in England initially

Health officials prioritize patients with the greatest need for the "King Kong of weight-loss drugs," tirzepatide. Initial rollout over 12 years aims to protect NHS services. Only those with BMI over 35 and weight-related illness will receive the drug initially.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.